Part of MOH Holdings Pte Ltd., Singapore Health Services Pte Ltd. is a Singaporean company located in Singapore. The firm provides medical services. Ivy Ng is the CEO, in this role since 2012.

Immuno-Biological Laboratories Co., Ltd. engages in the manufacture and sale of antibody-related reagents and pharmaceutical products. It operates through the following segments: Diagnostics and Reagents, Genetically Modified Silkworm, Testing, and Cosmetics-related. The Diagnostics and Reagents segment deals with the research and development of reagents and pharmaceutical products as well as in vitro diagnostic pharmaceuticals. The Genetically Modified Silkworm segment sells products using the cocoon of genetically modified silkworm. The Testing segment offers prevention and diagnostic support on top of drug discovery and research support in lifestyle-related diseases using lipid metabolism analysis technology. The Cosmetics-related segment develops and manufactures cosmetic products containing Neosilk-Human Collagen I. The company was founded on September 9, 1982 and is headquartered in Fujioka, Japan.

Nanjing Drum Tower Hospital is a private company headquartered in China. The firm provides medical services.

Nanjing Gulou Hospital is a Chinese private company located in Nanjing. The firm operates as a hospital.

Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China.

Exosome Diagnostics is developing biofluid-based molecular diagnostic tests for use in personalized medicine. Exosomes and other microvesicles are shed into all biofluids, including blood, urine and cerebrospinal fluid, forming a highly enriched source of intact, disease-specific nucleic acids. The Company's proprietary exosome technology makes use of this natural enrichment to achieve high sensitivity and specificity for rare gene transcripts and the expression of genes responsible for cancers and other diseases.

Songbo (Guangzhou) Biopharmaceutical Co., Ltd., established on 2021-12-20, Business scope includes biomass energy technology services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Research and development of bio-based material polymerization technology;Biochemical product technology research and development;Biomass energy resource database information system platform;Pharmaceutical special equipment manufacturing;R&D and application of cell technology;Health Consulting Services(Does not include medical services);Pharmaceutical special equipment sales;Medical Research and Experimental Development;Organ biochemical pharmaceutical machinery manufacturing;Manufacturing of bio-based materials;Pharmaceutical commissioned production;pharmaceutical production;

Jichi Medical University (自治医科大学 Jichi ika daigaku) is a private university in Shimotsuke, Tochigi, Japan, established in 1972. In 2008 the Gates Foundation awarded $100,000 to Hiroyuki Matsuoka, a medical researcher at the university, to do research on flying syringes.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Amager and Hvidovre Hospital is all about life. Life is about saving lives and giving life to the world. The quality of life for the patients and a good working environment for the employees. They Are ready with expertise and care around the clock. It is important for the patient to transition quickly from diagnosis to treatment and to return safely to everyday life. They act competently and carefully, even when life is at its worst. They are experts in folk diseases - the diseases that most people suffer from. In addition, they can provide highly specialized treatment to patients with rare diseases. They are proud of both. The work of hundreds of researchers every day is vital to the improvement and saving of lives. They develop and share new knowledge - it creates strong professional environments. The professionalism and development of all employees ensures good treatment of patients and an exciting working environment.

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. Since its establishment in 1983 the company has been dedicated to improving the lives of patients. Octapharma was founded in 1983 on the fundamental principle of improving the lives of patients. Since then we have remained focused on our collective responsibility for the trust instilled in us by physicians and patients worldwide. In 2012, the Octapharma Board identified the core strategic pillars which will lead to the achievement of the organization’s ambitious long term goals.

Manufactures pharmaceuticals